The benefits of early diagnosis of chronic kidney disease (CKD) are significant, as patients in whom CKD is diagnosed in the early stages have the chance to make lifestyle changes, learn how to manage their disease, and extend their lives while avoiding or postponing the need for dialysis or transplant.
The American College of Cardiology and American Heart Association have released a new evidence-based guideline detailing the primary prevention of cardiovascular disease.
Paclitaxel-coated devices were associated with an approximately 50% increased risk of death when compared with control devices.
The certifications will establish comprehensive, evidence-based standards for cardiac and stroke care.
Data include statistics on tobacco use, cardiovascular health, physical activity, nutrition, blood pressure, and cholesterol, among others.
The American Heart Association has updated its scientific statement on blood pressure readings.
The investigators of this study sought to examine the impact of income inequality on heart failure outcomes among different countries.
In order to revise the guidelines, the Task Force reviewed clinical trials presented at the annual scientific meetings of the ACC, AHA, HRS, and European Society of Cardiology in addition to other peer-reviewed, published data.
The risk for cardiovascular disease and all-cause mortality have been correlated with income drops and volatility.
The pea-sized device is a self-expanding wire mesh that is inserted through an incision in the leg and guided through vessels to the heart, where it is placed to seal the opening.
